Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Arterial Occlusive Disease | Research article

Molecular mechanisms of hydrogen sulfide against uremic accelerated atherosclerosis through cPKCβII/Akt signal pathway

Authors: Ruifang Xiong, Xiangxue Lu, Jinghong Song, Han Li, Shixiang Wang

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Cardiovascular disease is the most common complication and leading cause of death in maintenance hemodialysis patients. The protection mechanism of hydrogen sulfide (H2S) and the specific role of conventional protein kinase C βII (cPKCβII)/Akt signaling pathway in the formation of atherosclerosis is still controversial.

Methods

8-week-old male ApoE−/− mice were treated with 5/6 nephrectomy and high-fat diet to make uremia accelerated atherosclerosis (UAAS) model. Mice were divided into normal control group (control group), sham operation group (sham group), UAAS group, L-cysteine group (UAAS+L-cys group), sodium hydrosulfide group (UAAS+NaHS group), and propargylglycine group (UAAS+PPG group). Western blot was used to detect cPKCβII activation, Akt phosphorylation and endothelial nitric oxide synthase (eNOS) expression in mice aorta.

Results

The membrane translocation of cPKCβII in UAAS group was higher than sham group, and L-cys or NaHS injection could suppress the membrane translocation, but PPG treatment resulted in more membrane translocation of cPKCβII (P < 0.05, n = 6 per group). Akt phosphorylation and the eNOS expression in UAAS group was lower than sham group, and L-cys or NaHS injection could suppress the degradation of Akt phosphorylation and the eNOS expression, but PPG treatment resulted in more decrease in the Akt phosphorylation and the eNOS expression (P < 0.05, n = 6 per group).

Conclusion

Endogenous cystathionine-γ-lyase (CSE)/H2S system protected against the formation of UAAS via cPKCβII/Akt signal pathway. The imbalance of CSE/H2S system may participate in the formation of UAAS by affecting the expression of downstream molecule eNOS, which may be mediated by cPKCβII/Akt signaling pathway.
Literature
1.
go back to reference Christoffersen C, Bartels ED, Aarup A, Nielsen LB, Pedersen TX. ApoB and apoM - new aspects of lipoprotein biology in uremia-induced atherosclerosis. Eur J Pharmacol. 2017;816:154–60.CrossRef Christoffersen C, Bartels ED, Aarup A, Nielsen LB, Pedersen TX. ApoB and apoM - new aspects of lipoprotein biology in uremia-induced atherosclerosis. Eur J Pharmacol. 2017;816:154–60.CrossRef
2.
go back to reference Whitman IR, Feldman HI, Deo R. CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol. 2012;23(12):1929–39.CrossRef Whitman IR, Feldman HI, Deo R. CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol. 2012;23(12):1929–39.CrossRef
3.
go back to reference Bosteen MH, Madsen Svarrer EM, Bisgaard LS, Martinussen T, Madsen M, Nielsen LB, Christoffersen C, Pedersen TX. Effects of apolipoprotein M in uremic atherosclerosis. Atherosclerosis. 2017;265:93–101.CrossRef Bosteen MH, Madsen Svarrer EM, Bisgaard LS, Martinussen T, Madsen M, Nielsen LB, Christoffersen C, Pedersen TX. Effects of apolipoprotein M in uremic atherosclerosis. Atherosclerosis. 2017;265:93–101.CrossRef
4.
go back to reference Yamaguchi S, Gohda T, Gotoh H, Omote K, Furukawa M, Ishikawa Y, Tomino Y. Factors associated with cardiovascular death and events in patients with end stage renal disease. Nihon Jinzo Gakkai Shi. 2013;55(2):159–66.PubMed Yamaguchi S, Gohda T, Gotoh H, Omote K, Furukawa M, Ishikawa Y, Tomino Y. Factors associated with cardiovascular death and events in patients with end stage renal disease. Nihon Jinzo Gakkai Shi. 2013;55(2):159–66.PubMed
5.
go back to reference Yamagata K. Docosahexaenoic acid regulates vascular endothelial cell function and prevents cardiovascular disease. Lipids Health Dis. 2017;16(1):118.CrossRef Yamagata K. Docosahexaenoic acid regulates vascular endothelial cell function and prevents cardiovascular disease. Lipids Health Dis. 2017;16(1):118.CrossRef
6.
go back to reference Feng SJ, Li H, Wang SX. Lower hydrogen sulfide is associated with cardiovascular mortality, which involves cPKCbetaII/Akt pathway in chronic hemodialysis patients. Blood Purif. 2015;40(3):260–9.CrossRef Feng SJ, Li H, Wang SX. Lower hydrogen sulfide is associated with cardiovascular mortality, which involves cPKCbetaII/Akt pathway in chronic hemodialysis patients. Blood Purif. 2015;40(3):260–9.CrossRef
7.
go back to reference Li H, Feng SJ, Zhang GZ, Wang SX. Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy. Blood Purif. 2014;38(3–4):188–94.CrossRef Li H, Feng SJ, Zhang GZ, Wang SX. Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy. Blood Purif. 2014;38(3–4):188–94.CrossRef
8.
go back to reference Li L, Xu S, Yan J, Li Y, Wang X, Du R, Zhu J, Fu X, Xiao X, Wang Z. Mechanism of PKC activity affecting the adhesion reaction of endothelial cells with monocytes. Int J Cardiol. 2015;182:361–7.CrossRef Li L, Xu S, Yan J, Li Y, Wang X, Du R, Zhu J, Fu X, Xiao X, Wang Z. Mechanism of PKC activity affecting the adhesion reaction of endothelial cells with monocytes. Int J Cardiol. 2015;182:361–7.CrossRef
9.
go back to reference Gonzalez E, McGraw TE. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle. 2009;8(16):2502–8.CrossRef Gonzalez E, McGraw TE. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle. 2009;8(16):2502–8.CrossRef
10.
go back to reference Li Q, Park K, Xia Y, Matsumoto M, Qi W, Fu J, Yokomizo H, Khamaisi M, Wang X, Rask-Madsen C, et al. Regulation of macrophage apoptosis and atherosclerosis by lipid-induced PKCdelta isoform activation. Circ Res. 2017;121(10):1153–67.CrossRef Li Q, Park K, Xia Y, Matsumoto M, Qi W, Fu J, Yokomizo H, Khamaisi M, Wang X, Rask-Madsen C, et al. Regulation of macrophage apoptosis and atherosclerosis by lipid-induced PKCdelta isoform activation. Circ Res. 2017;121(10):1153–67.CrossRef
11.
go back to reference Wang G, Chen Z, Zhang F, Jing H, Xu W, Ning S, Li Z, Liu K, Yao J, Tian X. Blockade of PKCbeta protects against remote organ injury induced by intestinal ischemia and reperfusion via a p66shc-mediated mitochondrial apoptotic pathway. Apoptosis. 2014;19(9):1342–53.CrossRef Wang G, Chen Z, Zhang F, Jing H, Xu W, Ning S, Li Z, Liu K, Yao J, Tian X. Blockade of PKCbeta protects against remote organ injury induced by intestinal ischemia and reperfusion via a p66shc-mediated mitochondrial apoptotic pathway. Apoptosis. 2014;19(9):1342–53.CrossRef
12.
go back to reference Yetik-Anacak G, Sevin G, Ozzayim O, Dereli MV, Ahmed A. Hydrogen sulfide: a novel mechanism for the vascular protection by resveratrol under oxidative stress in mouse aorta. Vasc Pharmacol. 2016;87:76–82.CrossRef Yetik-Anacak G, Sevin G, Ozzayim O, Dereli MV, Ahmed A. Hydrogen sulfide: a novel mechanism for the vascular protection by resveratrol under oxidative stress in mouse aorta. Vasc Pharmacol. 2016;87:76–82.CrossRef
13.
go back to reference Tabit CE, Shenouda SM, Holbrook M, Fetterman JL, Kiani S, Frame AA, Kluge MA, Held A, Dohadwala MM, Gokce N, et al. Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation. 2013;127(1):86–95.CrossRef Tabit CE, Shenouda SM, Holbrook M, Fetterman JL, Kiani S, Frame AA, Kluge MA, Held A, Dohadwala MM, Gokce N, et al. Protein kinase C-beta contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation. 2013;127(1):86–95.CrossRef
14.
go back to reference Du C, Lin X, Xu W, Zheng F, Cai J, Yang J, Cui Q, Tang C, Cai J, Xu G, et al. Sulfhydrated sirtuin-1 increasing its deacetylation activity is an essential epigenetics mechanism of anti-atherogenesis by hydrogen sulfide. Antioxid Redox Signal. 2019;30(2):184–97.CrossRef Du C, Lin X, Xu W, Zheng F, Cai J, Yang J, Cui Q, Tang C, Cai J, Xu G, et al. Sulfhydrated sirtuin-1 increasing its deacetylation activity is an essential epigenetics mechanism of anti-atherogenesis by hydrogen sulfide. Antioxid Redox Signal. 2019;30(2):184–97.CrossRef
15.
go back to reference Xu S, Liu Z, Liu P. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis. Int J Cardiol. 2014;172(2):313–7.CrossRef Xu S, Liu Z, Liu P. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis. Int J Cardiol. 2014;172(2):313–7.CrossRef
16.
go back to reference Nalli AD, Bhattacharya S, Wang H, Kendig DM, Grider JR, Murthy KS. Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide. Am J Physiol Gastrointest Liver Physiol. 2017;313(4):G330–41.CrossRef Nalli AD, Bhattacharya S, Wang H, Kendig DM, Grider JR, Murthy KS. Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide. Am J Physiol Gastrointest Liver Physiol. 2017;313(4):G330–41.CrossRef
17.
go back to reference Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drueke TB, et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol. 2005;16(1):109–16.CrossRef Massy ZA, Ivanovski O, Nguyen-Khoa T, Angulo J, Szumilak D, Mothu N, Phan O, Daudon M, Lacour B, Drueke TB, et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol. 2005;16(1):109–16.CrossRef
18.
go back to reference Panthi S, Chung HJ, Jung J, Jeong NY. Physiological importance of hydrogen sulfide: emerging potent neuroprotector and neuromodulator. Oxidative Med Cell Longev. 2016;2016:9049782.CrossRef Panthi S, Chung HJ, Jung J, Jeong NY. Physiological importance of hydrogen sulfide: emerging potent neuroprotector and neuromodulator. Oxidative Med Cell Longev. 2016;2016:9049782.CrossRef
19.
go back to reference Weber GJ, Pushpakumar SB, Sen U. Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism. Am J Physiol Heart Circ Physiol. 2017;312(5):H874–85.CrossRef Weber GJ, Pushpakumar SB, Sen U. Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism. Am J Physiol Heart Circ Physiol. 2017;312(5):H874–85.CrossRef
20.
go back to reference Wuttke A, Yu Q, Tengholm A. Autocrine signaling underlies fast repetitive plasma membrane translocation of conventional and novel protein kinase C isoforms in beta cells. J Biol Chem. 2016;291(29):14986–95.CrossRef Wuttke A, Yu Q, Tengholm A. Autocrine signaling underlies fast repetitive plasma membrane translocation of conventional and novel protein kinase C isoforms in beta cells. J Biol Chem. 2016;291(29):14986–95.CrossRef
21.
go back to reference Shi Y, Cosentino F, Camici GG, Akhmedov A, Vanhoutte PM, Tanner FC, Luscher TF. Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arterioscler Thromb Vasc Biol. 2011;31(9):2090–7.CrossRef Shi Y, Cosentino F, Camici GG, Akhmedov A, Vanhoutte PM, Tanner FC, Luscher TF. Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arterioscler Thromb Vasc Biol. 2011;31(9):2090–7.CrossRef
22.
go back to reference Durpes MC, Morin C, Paquin-Veillet J, Beland R, Pare M, Guimond MO, Rekhter M, King GL, Geraldes P. PKC-beta activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis. Cardiovasc Res. 2015;106(2):303–13.CrossRef Durpes MC, Morin C, Paquin-Veillet J, Beland R, Pare M, Guimond MO, Rekhter M, King GL, Geraldes P. PKC-beta activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis. Cardiovasc Res. 2015;106(2):303–13.CrossRef
23.
go back to reference Wang W, Feng SJ, Li H, Zhang XD, Wang SX. Correlation of lower concentrations of hydrogen sulfide with activation of protein kinase CbetaII in uremic accelerated atherosclerosis patients. Chin Med J. 2015;128(11):1465–70.CrossRef Wang W, Feng SJ, Li H, Zhang XD, Wang SX. Correlation of lower concentrations of hydrogen sulfide with activation of protein kinase CbetaII in uremic accelerated atherosclerosis patients. Chin Med J. 2015;128(11):1465–70.CrossRef
24.
go back to reference Zhang Y, Li L, You J, Cao J, Fu X. Effect of 7-difluoromethyl-5, 4′-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(−/−) mice induced by a cholesterol-rich diet. Drug Des Devel Ther. 2013;7:233–42.CrossRef Zhang Y, Li L, You J, Cao J, Fu X. Effect of 7-difluoromethyl-5, 4′-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(−/−) mice induced by a cholesterol-rich diet. Drug Des Devel Ther. 2013;7:233–42.CrossRef
25.
go back to reference Jawień J, Nastałek P, Korbut R. Mouse models of experimental atherosclerosis. J Physiol Pharmacol. 2004;55(3):503–17.PubMed Jawień J, Nastałek P, Korbut R. Mouse models of experimental atherosclerosis. J Physiol Pharmacol. 2004;55(3):503–17.PubMed
26.
go back to reference Fukuto JM, Carrington SJ, Tantillo DJ, Harrison JG, Ignarro LJ, Freeman BA, Chen A, Wink DA. Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. Chem Res Toxicol. 2012;25(4):769–93.CrossRef Fukuto JM, Carrington SJ, Tantillo DJ, Harrison JG, Ignarro LJ, Freeman BA, Chen A, Wink DA. Small molecule signaling agents: the integrated chemistry and biochemistry of nitrogen oxides, oxides of carbon, dioxygen, hydrogen sulfide, and their derived species. Chem Res Toxicol. 2012;25(4):769–93.CrossRef
27.
go back to reference Fix SM, Borden MA, Dayton PA. Therapeutic gas delivery via microbubbles and liposomes. J Control Release. 2015;209:139–49.CrossRef Fix SM, Borden MA, Dayton PA. Therapeutic gas delivery via microbubbles and liposomes. J Control Release. 2015;209:139–49.CrossRef
28.
go back to reference Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Inducible nitric oxide synthase as a possible target in hypertension. Curr Drug Targets. 2014;15(2):164–74.CrossRef Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Inducible nitric oxide synthase as a possible target in hypertension. Curr Drug Targets. 2014;15(2):164–74.CrossRef
29.
go back to reference Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci. 2015;129(2):83–94.CrossRef Zhao Y, Vanhoutte PM, Leung SW. Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci. 2015;129(2):83–94.CrossRef
30.
go back to reference Dusting GJ. Nitric oxide in coronary artery disease: roles in atherosclerosis, myocardial reperfusion and heart failure. EXS. 1996;76:33–55.PubMed Dusting GJ. Nitric oxide in coronary artery disease: roles in atherosclerosis, myocardial reperfusion and heart failure. EXS. 1996;76:33–55.PubMed
31.
go back to reference Tsikas D, Bollenbach A, Hanff E, Kayacelebi AA. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Cardiovasc Diabetol. 2018;17(1):1.CrossRef Tsikas D, Bollenbach A, Hanff E, Kayacelebi AA. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Cardiovasc Diabetol. 2018;17(1):1.CrossRef
32.
go back to reference Kida M, Sugiyama T, Yoshimoto T, Ogawa Y. Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells. Eur J Pharm Sci. 2013;48(1–2):211–5.CrossRef Kida M, Sugiyama T, Yoshimoto T, Ogawa Y. Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells. Eur J Pharm Sci. 2013;48(1–2):211–5.CrossRef
33.
go back to reference Lin Y, Chen Y, Zhu N, Zhao S, Fan J, Liu E. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation. Biomed Pharmacother. 2016;83:466–76.CrossRef Lin Y, Chen Y, Zhu N, Zhao S, Fan J, Liu E. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation. Biomed Pharmacother. 2016;83:466–76.CrossRef
34.
go back to reference Kram L, Grambow E, Mueller-Graf F, Sorg H, Vollmar B. The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases. Thromb Res. 2013;132(2):e112–7.CrossRef Kram L, Grambow E, Mueller-Graf F, Sorg H, Vollmar B. The anti-thrombotic effect of hydrogen sulfide is partly mediated by an upregulation of nitric oxide synthases. Thromb Res. 2013;132(2):e112–7.CrossRef
35.
go back to reference Qin W, Ren B, Wang S, Liang S, He B, Shi X, Wang L, Liang J, Wu F. Apigenin and naringenin ameliorate PKCbetaII-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high glucose. Vasc Pharmacol. 2016;85:39–49.CrossRef Qin W, Ren B, Wang S, Liang S, He B, Shi X, Wang L, Liang J, Wu F. Apigenin and naringenin ameliorate PKCbetaII-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high glucose. Vasc Pharmacol. 2016;85:39–49.CrossRef
36.
go back to reference Das SK, Yuan YF, Li MQ. Specific PKC betaII inhibitor: one stone two birds in the treatment of diabetic foot ulcers. Biosci Rep. 2018;38(5). Das SK, Yuan YF, Li MQ. Specific PKC betaII inhibitor: one stone two birds in the treatment of diabetic foot ulcers. Biosci Rep. 2018;38(5).
Metadata
Title
Molecular mechanisms of hydrogen sulfide against uremic accelerated atherosclerosis through cPKCβII/Akt signal pathway
Authors
Ruifang Xiong
Xiangxue Lu
Jinghong Song
Han Li
Shixiang Wang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1550-4

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue